The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer. [electronic resource]
- The Prostate Dec 2008
- 1798-805 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0045
10.1002/pros.20842 doi
3-Oxo-5-alpha-Steroid 4-Dehydrogenase--genetics Adenocarcinoma--genetics Age of Onset Aged Aged, 80 and over Case-Control Studies Disease Progression Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease--genetics Genotype Humans Male Middle Aged Pilot Projects Polymorphism, Single Nucleotide--genetics Prostatic Neoplasms--genetics Risk Factors Severity of Illness Index